Cancer, Advanced Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03383094Chemoradiation vs Immunotherapy and Radiation for Head and Neck CancerTreatment
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Treatment
NCT03029403Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube CancerTreatment
NCT03425565A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell CancerTreatment